Specific targeting of lung ILC2s via NRP1 in pulmonary fibrosis

被引：3
|
作者：
Nii, Takuro [1 ]
Fukushima, Kiyoharu [1 ,2 ,3 ,4 ,5 ]
Kida, Hiroshi [1 ,2 ]
机构：
[1] Natl Hosp Org Osaka Toneyama Med Ctr, Dept Resp Med, 5-1-1 Toneyama, Osaka, Japan
[2] Osaka Univ, Dept Resp Med & Clin Immunol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka, Japan
[3] Osaka Univ, World Premier Inst Immunol Frontier Res Ctr WPI I, Host Def Lab, 3-1 Yamadaoka, Suita, Osaka, Japan
[4] Osaka Univ, Res Inst Microbial Dis RIMD, Dept Host Def, Osaka 5650871, Japan
[5] Global Ctr Med Engn & Informat, 2-2 Yamadaoka, Suita, Osaka, Japan
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2022年 / 19卷 / 08期
关键词：
EXPRESSION;
D O I：
10.1038/s41423-022-00867-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：869 / 871
页数：3
相关论文
共 50 条
  • [21] MicroRNA-365 inhibits growth, invasion and metastasis of lung cancer by targeting NRP1 expression
    Cao, Guangxin
    Li, Fenghua
    Du, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1081 - 1092
  • [22] Blimp-1 expressing lung ILC2s are a distinct cell population in allergic asthma
    Zhang, Jinyi
    He, Kun
    Ford, B. Rhodes
    Hettinga, Angela
    Poholek, Amanda C.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [23] IL-5-producing ILC2s and eosinophils in the development of pulmonary arteriopathy
    Takaki, Satoshi
    CYTOKINE, 2017, 100 : 64 - 64
  • [24] ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
    Moral, John Alec
    Leung, Joanne
    Rojas, Luis A.
    Ruan, Jennifer
    Zhao, Julia
    Sethna, Zachary
    Ramnarain, Anita
    Gasmi, Billel
    Gururajan, Murali
    Redmond, David
    Askan, Gokce
    Bhanot, Umesh
    Elyada, Ela
    Park, Youngkyu
    Tuveson, David A.
    Gonen, Mithat
    Leach, Steven D.
    Wolchok, Jedd D.
    DeMatteo, Ronald P.
    Merghoub, Taha
    Balachandran, Vinod P.
    NATURE, 2020, 579 (7797) : 130 - +
  • [25] ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
    John Alec Moral
    Joanne Leung
    Luis A. Rojas
    Jennifer Ruan
    Julia Zhao
    Zachary Sethna
    Anita Ramnarain
    Billel Gasmi
    Murali Gururajan
    David Redmond
    Gokce Askan
    Umesh Bhanot
    Ela Elyada
    Youngkyu Park
    David A. Tuveson
    Mithat Gönen
    Steven D. Leach
    Jedd D. Wolchok
    Ronald P. DeMatteo
    Taha Merghoub
    Vinod P. Balachandran
    Nature, 2020, 579 : 130 - 135
  • [26] MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
    Xu, Dan
    Chen, Xiaofeng
    He, Quanyong
    Luo, Chengqun
    ONCOTARGETS AND THERAPY, 2016, 9 : 7047 - 7057
  • [27] The transcription factor GATA3 positively regulates NRP1 to promote radiation-induced pulmonary fibrosis
    Yi, Junxuan
    Gao, Hui
    Wei, Xinfeng
    Wang, Mingwei
    Xu, Weiqiang
    Yu, Duo
    Zhao, Mingqi
    Zhao, Mengdie
    Wang, Zhicheng
    Wei, Wei
    Jin, Shunzi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 262
  • [28] Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease
    Donovan, Chantal
    Starkey, Malcolm R.
    Kim, Richard Y.
    Rana, Batika M. J.
    Barlow, Jillian L.
    Jones, Bernadette
    Haw, Tatt Jhong
    Mono Nair, Prema
    Budden, Kurtis
    Cameron, Guy J. M.
    Horvat, Jay C.
    Wark, Peter A.
    Foster, Paul S.
    McKenzie, Andrew N. J.
    Hansbro, Philip M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (01) : 143 - 150
  • [29] Insilico targeting of virus entry facilitator NRP1 to block SARS-CoV2 entry
    Bibi, Nousheen
    Shah, Maleeha
    Khan, Shahzad
    Chohan, Muhammad Shahzad
    Kamal, Mohammad Amjad
    PLOS ONE, 2025, 20 (02):
  • [30] Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections
    Cui Wang
    Zhaoxiang Du
    Ranhui Li
    Ying Luo
    Cuiming Zhu
    Nan Ding
    Aihua Lei
    Journal of Molecular Medicine, 2023, 101 : 947 - 959
12345